A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults
Julie E. Ledgerwood(Vaccine Research Institute of San Diego), Barney S. Graham(National Institutes of Health), Pamela Costner(National Institutes of Health), Charla Andrews(National Institutes of Health), Richard A. Koup(Aaron Diamond AIDS Research Center), Sabue Mulangu(National Institutes of Health), Mary E. Enama(National Institutes of Health), Galina V. Yamshchikov(National Institutes of Health), Rebecca Sheets(National Institutes of Health), Niraj M. Desai(Johns Hopkins University), Gary J. Nabel(National Institutes of Health), Robert T. Bailer(National Institutes of Health), John R. Mascola(National Institute of Allergy and Infectious Diseases), Maria Grazia Pau, Zongyi Hu(National Institutes of Health), Mario Roederer(National Institutes of Health), LaSonji A. Holman(National Institutes of Health), Jaap Goudsmit(Harvard University), Nancy J. Sullivan(National Institute of Allergy and Infectious Diseases)
Cited by 211
Related Papers
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
|Science|2020|9.8k
A human memory T cell subset with stem cell–like properties
|Nature Medicine|2011|2k
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation
|Journal of Immunological Methods|2003|1.6k